Clin2
NCT07444294Likely a fitRecruiting

Study of SRK-439 in healthy adults

Healthy

This trial tests a new drug, SRK-439, in healthy adults to see how safe it is and how the body processes it. It helps learn the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
76 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • Your body mass index (BMI) is between 18 and 35.
  • You have never taken SRK-439 or similar drugs that target muscle growth.
  • You haven't used anabolic steroids, growth hormones, or muscle-building supplements in the last 3 months.
  • You have not had cancer treatment or immune-suppressing therapy in the past year.
  • You haven't taken any other experimental drugs in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai
NCT07409922Recruiting· Phase 1
Testing KR23343 in healthy volunteers

This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.

Shanghai
NCT07823764Not yet recruiting· Phase 1
Testing a new antibody drug in healthy volunteers

This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.

Hangzhou, Zhejiang
NCT06926218Not yet recruiting· Phase 1
Safety study of HSK47388 in healthy adults

This trial tests a new medicine called HSK47388 to see if it is safe and how the body processes it. It is an early-stage study in healthy adults aged 18 to 55.

Adelaide
NCT07745751Not yet recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new medicine called TRT-448 in healthy adults to see if it is safe and how the body processes it. It is a first-in-human study, meaning the drug has not been given to people before.

NCT07407543Recruiting· Phase 1
Study of SRN001 in healthy Korean and Caucasian men

This trial tests a new drug called SRN001 in healthy men to see how safe it is and how the body processes it. It may help find the right dose for future studies.

Seoul

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.